Document is current
Any future updates will be listed below
-
Authors
Gehrke, Nadine
Wörns, Marcus A.
Mann, Amrit
Hövelmeyer, Nadine
Waisman, Ari https://orcid.org/0000-0003-4304-8234
Straub, Beate K.
Galle, Peter R.
Schattenberg, Jörn M. https://orcid.org/0000-0002-4224-4703
- License Information
-
More Information
Article History
Received: 5 November 2021
Revised: 11 May 2022
Accepted: 12 May 2022
First Online: 31 May 2022
Competing interests
: JMS reports Consultancy: BMS, Boehringer Ingelheim, Echosens, Genfit, Gilead Sciences, Intercept Pharmaceuticals, Madrigal, Merck, Nordic Bioscience, Novartis, Pfizer, Roche, Sanofi, Siemens Healthcare GmbH. Research Funding: Gilead Sciences, Boehringer Ingelheim, Siemens Healthcare GmbH. Speaker Honorarium: Falk Foundation. The other authors declare no competing interests.
: All applicable national and institutional guidelines for the care and use of animals were followed.
